International Parkinson and Movement Disorder Society is a professional society focused on improving care for patients with movement disorders through education and research.

International Parkinson and Movement Disorder Society

International Parkinson and Movement Disorder Society | 9,474 followers on LinkedIn. MDS is a professional society of over 10,000 clinicians, scientists and other healthcare professionals dedicated to improving the care of patients with movement disorders through education and research.

In recent years, there has been tremendous growth in new diagnostic information, pharmacological and neurosurgical treatments for Movement Disorders, as well as a greater understanding of impaired motor control function. MDS offers you and your patients an essential link to this knowledge.

Asst. Director of Communications - International Parkinson and Movement Disorder Society

Shea Higgins

Digital Biomarkers | Digital Medicine | Director of the Brain Diseases Analysis Laboratory at BUT | Co-Founder and Chief Scientific Officer at Scicake

Jiri Mekyska

Meetings Manager at Movement Disorder Society

Shannon Fraaza

This is the International Secretariat of MDS. Please join our LinkedIn Group & follow the company page for more updates.

MDS International Secretariat

Submit your late-breaking abstract for the 2025 AOPMC: https://loom.ly/-MGAYQA

How do we shake? Dr. Rick Helmich shares his expertise on the pathophysiology of tremor and how functional MRI can help understand the circuits of different tremor disorders. https://loom.ly/rV_N0Gw

Shaurjya Mandal explains how AI can help recognize difficult-to-diagnose dystonias by breaking down movements across each joint in hundreds of thousands of videos. https://loom.ly/Vm3zgmo

Movement disorders are often some of the most impactful symptoms on quality of life for people with metabolic issues. Learn to better diagnose these difficult-to-distinguish diseases. https://loom.ly/BwnCK4o

Dr. Micol Avenali shares her research to answer the "burning issue" of whether DBS affects cognitive decline in GBA-PD patients. https://loom.ly/8hiFhEg

Researchers mined a large U.S. claims database to examine patterns of prescription medication use among patients with essential tremor. Interestingly, only 25% used propranolol, the one FDA-approved drug to treat ET, and use of multiple drugs over a 2-year period was common. https://loom.ly/p6ylFlg

How can studying transcutaneous spinal cord stimulation (tSCS) help reveal potential pathophysiological mechanisms of essential tremor? Dr. Anna Latorre shares how studying tSCS can provide benefits for ET patients and future research. https://loom.ly/MklwfCE

Could alpha-synuclein SAAs help differentiate atypical parkinsonian syndromes from PD? Dr. Edwin Jabbari explains the challenges presented by copathologies. https://loom.ly/8hiFhEg

Apply to join the MDS Social Media Editorial Board Help the Society develop strategies to engage on a variety of platforms. Apply now: https://lnkd.in/e9jYkRD3

How can biological assays for diagnosis of α-synucleinopathies be improved? This seeding amplification immunoassay (SAIA) adds a quantitative measurement applicable to the clinical setting. https://loom.ly/Vm3zgmo

MOVE

ORG:MOVEMENTDISORDERS

International Parkinson and Movement Disorder Society